NeuroPace Inc (NASDAQ: NPCE) open the trading on Wednesday, with a bit cautious approach as it glided -1.20% to $16.5, before settling in for the price of $16.7 at the close. Taking a more long-term approach, NPCE posted a 52-week range of $7.56-$18.98.
The Healthcare sector firm’s twelve-monthly sales growth has been 5.83% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 5.83%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 18.23%. This publicly-traded company’s shares outstanding now amounts to $33.28 million, simultaneously with a float of $24.79 million. The organization now has a market capitalization sitting at $549.58 million. At the time of writing, stock’s 50-day Moving Average stood at $11.52, while the 200-day Moving Average is $11.31.
NeuroPace Inc (NPCE) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Devices industry. NeuroPace Inc’s current insider ownership accounts for 25.56%, in contrast to 70.17% institutional ownership. According to the most recent insider trade that took place on May 14 ’25, this organization’s 10% Owner sold 168,136 shares at the rate of 15.85, making the entire transaction reach 2,665,333 in total value, affecting insider ownership by 3,238,199. Preceding that transaction, on Feb 21 ’25, Company’s CHIEF MEDICAL OFFICER sold 78,334 for 13.72, making the whole transaction’s value amount to 1,074,844. This particular insider is now the holder of 81,993 in total.
NeuroPace Inc (NPCE) Earnings and Revenue Records
NeuroPace Inc’s EPS increase for this current 12-month fiscal period is 18.23% and is forecasted to reach -0.64 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 32.13% through the next 5 years, which can be compared against the 5.83% growth it accomplished over the previous five years trading on the market.
NeuroPace Inc (NASDAQ: NPCE) Trading Performance Indicators
Let’s observe the current performance indicators for NeuroPace Inc (NPCE). It’s Quick Ratio in the last reported quarter now stands at 3.94. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.79.
In the same vein, NPCE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.75, a figure that is expected to reach -0.18 in the next quarter, and analysts are predicting that it will be -0.64 at the market close of one year from today.
Technical Analysis of NeuroPace Inc (NPCE)
[NeuroPace Inc, NPCE] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 95.21% While, its Average True Range was 79.11.
Raw Stochastic average of NeuroPace Inc (NPCE) in the period of the previous 100 days is set at 95.61%, which indicates a major rise in contrast to 90.93% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.89 that was higher than 0.55 volatility it exhibited in the past 100-days period.
